| # | Country | Total Patents | |
|---|---|---|---|
| #1 | China | 5 | |
| #2 | United States | 3 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | Japan | 2 | |
| #5 | Canada | 1 | |
| #6 | EPO (European Patent Office) | 1 | |
| #7 | Republic of Korea | 1 | |
| #8 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Computer technology | |
| #3 | Organic fine chemistry | |
| #4 | Foods and drinks |
| # | Name | Total Patents |
|---|---|---|
| #1 | Farr Stephen J | 5 |
| #2 | Stewart Richard Alistair Balfour | 4 |
| #3 | Clarke Anthony | 4 |
| #4 | Galer Bradley S | 3 |
| #5 | Boyd Brooks M | 3 |
| #6 | Lieven Lagae | 2 |
| #7 | Peter De Witte | 2 |
| #8 | Londesbrough Derek | 2 |
| #9 | Joe Sulbron | 2 |
| #10 | Boyd Brooks | 2 |
| Publication | Filing date | Title |
|---|---|---|
| CN108883399A | Fenfluramine composition and preparation method thereof | |
| US2017071949A1 | Combination treatment of specific forms of epilepsy | |
| WO2017035267A1 | Methods of treating lennox-gastaut syndrome using fenfluramine | |
| JP2016216438A | Selective 5-ht receptor agonist and antagonist for treating dravet syndrome | |
| JP2017057188A | Combination therapy of specific form of epilepsy |